Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hwee Teoh

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Trends in Molecular Medicine|May 5, 2019
Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic RiskDaniella C Terenzi, Justin Z Trac, Hwee Teoh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 1, 2024
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stageBrady Park, Ehab Bakbak, Hwee Teoh, et al.
Atherosclerosis|December 22, 2015
Adiponectin limits monocytic microparticle-induced endothelial activation by modulation of the AMPK, Akt and NFκB signaling pathwaysMehroz Ehsan, Krishna K Singh, Fina Lovren, et al.
ESC Heart Failure|April 11, 2023
Impact of diabetes duration on left ventricular mass regression with empagliflozinMichael Moroney, Raj Verma, Makoto Hibino, et al.
ESC Heart Failure|April 11, 2023
Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodellingRaj Verma, Michael Moroney, Makoto Hibino, et al.
The American Journal of Cardiology|September 8, 2009
Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic diseaseHwee Teoh, Aurora A Mendelsohn, Shaun G Goodman, et al.
Diabetes Care|November 30, 2018
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical TrialLawrence A Leiter, Hwee Teoh, David Kallend, et al.
Cardiovascular Research|February 17, 2024
Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesityDaniella C Terenzi, Ehab Bakbak, Hwee Teoh, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 10, 2018
A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidationTariq R Altamimi, Biswajit Chowdhury, Krishna K Singh, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 9, 2009
Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosisFina Lovren, Yi Pan, Praphulla C Shukla, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Trends in Molecular Medicine|May 5, 2019
Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic RiskDaniella C Terenzi, Justin Z Trac, Hwee Teoh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 1, 2024
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stageBrady Park, Ehab Bakbak, Hwee Teoh, et al.
Atherosclerosis|December 22, 2015
Adiponectin limits monocytic microparticle-induced endothelial activation by modulation of the AMPK, Akt and NFκB signaling pathwaysMehroz Ehsan, Krishna K Singh, Fina Lovren, et al.
ESC Heart Failure|April 11, 2023
Impact of diabetes duration on left ventricular mass regression with empagliflozinMichael Moroney, Raj Verma, Makoto Hibino, et al.
ESC Heart Failure|April 11, 2023
Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodellingRaj Verma, Michael Moroney, Makoto Hibino, et al.
The American Journal of Cardiology|September 8, 2009
Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic diseaseHwee Teoh, Aurora A Mendelsohn, Shaun G Goodman, et al.
Diabetes Care|November 30, 2018
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical TrialLawrence A Leiter, Hwee Teoh, David Kallend, et al.
Cardiovascular Research|February 17, 2024
Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesityDaniella C Terenzi, Ehab Bakbak, Hwee Teoh, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 10, 2018
A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidationTariq R Altamimi, Biswajit Chowdhury, Krishna K Singh, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 9, 2009
Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosisFina Lovren, Yi Pan, Praphulla C Shukla, et al.
Pageof 13